Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 1975
A potential new brain-scanning agent: 4-77Br-2,5-dimethoxyphenylisoproplamine (4-Br-DPIA)
T Sargent, D A Kalbhen, A T Shulgin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1978
An iodinated catecholamine congener for brain imaging and metabolic studies
T Sargent, T F Budinger, G Braun, et al.
Journal of Chromatography
|
September 8, 1993
Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users
P Jacob, L Yu, G Liang, et al.
Communications in Psychopharmacology
|
January 1, 1978
Brain and retina uptake of a radio-iodine labeled psychotomimetic in dog and monkey
T Sargent, G Braun, U Braun, et al.
NIDA Research Monograph
|
January 1, 1978
Absolute configuration and psychotomimetic activity
G M Anderson, G Braun, U Braun, et al.
European Journal of Pharmacology
|
October 21, 1999
Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines
N V Cozzi, M K Sievert, A T Shulgin, et al.
Neuropharmacology
|
March 1, 1975
In vivo human pharmacodynamics of the psychodysleptic 4-BR-2,5-dimethoxyphenylisopropylamine labelled with 'BRor 'BR
T Sargent, D A Kalbhen, A T Shulgin, et al.
Journal of Medicinal Chemistry
|
October 1, 1986
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class
D E Nichols, A J Hoffman, R A Oberlender, et al.
European Journal of Pharmacology
|
June 4, 1987
Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain
D J McKenna, C A Mathis, A T Shulgin, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)
M A Parker, D Marona-Lewicka, D Kurrasch, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 1975
A potential new brain-scanning agent: 4-77Br-2,5-dimethoxyphenylisoproplamine (4-Br-DPIA)
T Sargent, D A Kalbhen, A T Shulgin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1978
An iodinated catecholamine congener for brain imaging and metabolic studies
T Sargent, T F Budinger, G Braun, et al.
Journal of Chromatography
|
September 8, 1993
Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users
P Jacob, L Yu, G Liang, et al.
Communications in Psychopharmacology
|
January 1, 1978
Brain and retina uptake of a radio-iodine labeled psychotomimetic in dog and monkey
T Sargent, G Braun, U Braun, et al.
NIDA Research Monograph
|
January 1, 1978
Absolute configuration and psychotomimetic activity
G M Anderson, G Braun, U Braun, et al.
European Journal of Pharmacology
|
October 21, 1999
Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines
N V Cozzi, M K Sievert, A T Shulgin, et al.
Neuropharmacology
|
March 1, 1975
In vivo human pharmacodynamics of the psychodysleptic 4-BR-2,5-dimethoxyphenylisopropylamine labelled with 'BRor 'BR
T Sargent, D A Kalbhen, A T Shulgin, et al.
Journal of Medicinal Chemistry
|
October 1, 1986
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class
D E Nichols, A J Hoffman, R A Oberlender, et al.
European Journal of Pharmacology
|
June 4, 1987
Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain
D J McKenna, C A Mathis, A T Shulgin, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)
M A Parker, D Marona-Lewicka, D Kurrasch, et al.
Page
of 7